A pilot exploratory study for analysis of clinical features and plasma catecholamines in blepharospasm

Abstract Blepharospasm (BSP) is a common focal movement disorder linked to the basal ganglia and plasma catecholamines (CAs). This study aimed to analyze clinical characteristics of BSP patients and explore the relationship with plasma CAs. Clinical characteristics, clinician-rated scales, and plasm...

Full description

Saved in:
Bibliographic Details
Main Authors: Lixia Zhu, Hongmei Meng, Wuqiong Zhang, Lijuan Wang, Weixuan Zhao, Jiaai Li, Nilupaer Shafeng, Huaiyu Sun, Ting Jiang, Huiqing Liu, Yu Guo, Shuai Hou
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-86922-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585686265364480
author Lixia Zhu
Hongmei Meng
Wuqiong Zhang
Lijuan Wang
Weixuan Zhao
Jiaai Li
Nilupaer Shafeng
Huaiyu Sun
Ting Jiang
Huiqing Liu
Yu Guo
Shuai Hou
author_facet Lixia Zhu
Hongmei Meng
Wuqiong Zhang
Lijuan Wang
Weixuan Zhao
Jiaai Li
Nilupaer Shafeng
Huaiyu Sun
Ting Jiang
Huiqing Liu
Yu Guo
Shuai Hou
author_sort Lixia Zhu
collection DOAJ
description Abstract Blepharospasm (BSP) is a common focal movement disorder linked to the basal ganglia and plasma catecholamines (CAs). This study aimed to analyze clinical characteristics of BSP patients and explore the relationship with plasma CAs. Clinical characteristics, clinician-rated scales, and plasma CAs were recorded, including dopamine (DA), 3-methoxytyramine (3-MT), and the 3-MT/DA ratio. Plasma CA levels were measured using liquid chromatography-tandem mass spectrometry. Clinical features, plasma CAs, and metabolite contents were compared between groups. Spearman’s correlation analysis examined the relationship between plasma CA levels, metabolites, and severity of BSP symptoms. We found that dry eye was an independent risk factor for BSP. Coffee consumption history was an independent protective factor against BSP. Compared to healthy controls, patients had increased DA and decreased 3-MT and 3-MT/DA levels. Anxiety severity negatively correlated with 3-MT and 3-MT/DA levels. The decreased 3-MT/DA ratio is more likely to be a potential biomarker of BSP. These findings highlight the importance of abnormal DA metabolism in BSP pathophysiology and suggest that anxiety symptoms may contribute to BSP pathogenesis by affecting CAs, providing new perspectives for future diagnosis, treatment, and prognostic evaluation of BSP.
format Article
id doaj-art-14274218f50c4e3d97cd48d68419d12c
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-14274218f50c4e3d97cd48d68419d12c2025-01-26T12:34:26ZengNature PortfolioScientific Reports2045-23222025-01-011511910.1038/s41598-025-86922-yA pilot exploratory study for analysis of clinical features and plasma catecholamines in blepharospasmLixia Zhu0Hongmei Meng1Wuqiong Zhang2Lijuan Wang3Weixuan Zhao4Jiaai Li5Nilupaer Shafeng6Huaiyu Sun7Ting Jiang8Huiqing Liu9Yu Guo10Shuai Hou11Department of Neurology, The First Hospital of Jilin UniversityDepartment of Neurology, The First Hospital of Jilin UniversityDepartment of Neurology, The First Hospital of Jilin UniversityDepartment of Neurology, The First Hospital of Jilin UniversityDepartment of Neurology, The First Hospital of Jilin UniversityDepartment of Neurology, The First Hospital of Jilin UniversityDepartment of Neurology, The First Hospital of Jilin UniversityDepartment of Neurology, The First Hospital of Jilin UniversityDepartment of Neurology, The First Hospital of Jilin UniversityDepartment of Neurology, The First Hospital of Jilin UniversityDepartment of Neurology, The First Hospital of Jilin UniversityDepartment of Neurology, The First Hospital of Jilin UniversityAbstract Blepharospasm (BSP) is a common focal movement disorder linked to the basal ganglia and plasma catecholamines (CAs). This study aimed to analyze clinical characteristics of BSP patients and explore the relationship with plasma CAs. Clinical characteristics, clinician-rated scales, and plasma CAs were recorded, including dopamine (DA), 3-methoxytyramine (3-MT), and the 3-MT/DA ratio. Plasma CA levels were measured using liquid chromatography-tandem mass spectrometry. Clinical features, plasma CAs, and metabolite contents were compared between groups. Spearman’s correlation analysis examined the relationship between plasma CA levels, metabolites, and severity of BSP symptoms. We found that dry eye was an independent risk factor for BSP. Coffee consumption history was an independent protective factor against BSP. Compared to healthy controls, patients had increased DA and decreased 3-MT and 3-MT/DA levels. Anxiety severity negatively correlated with 3-MT and 3-MT/DA levels. The decreased 3-MT/DA ratio is more likely to be a potential biomarker of BSP. These findings highlight the importance of abnormal DA metabolism in BSP pathophysiology and suggest that anxiety symptoms may contribute to BSP pathogenesis by affecting CAs, providing new perspectives for future diagnosis, treatment, and prognostic evaluation of BSP.https://doi.org/10.1038/s41598-025-86922-yBlepharospasmPathogenesisAnxietyCatecholamine3-methoxytyramine
spellingShingle Lixia Zhu
Hongmei Meng
Wuqiong Zhang
Lijuan Wang
Weixuan Zhao
Jiaai Li
Nilupaer Shafeng
Huaiyu Sun
Ting Jiang
Huiqing Liu
Yu Guo
Shuai Hou
A pilot exploratory study for analysis of clinical features and plasma catecholamines in blepharospasm
Scientific Reports
Blepharospasm
Pathogenesis
Anxiety
Catecholamine
3-methoxytyramine
title A pilot exploratory study for analysis of clinical features and plasma catecholamines in blepharospasm
title_full A pilot exploratory study for analysis of clinical features and plasma catecholamines in blepharospasm
title_fullStr A pilot exploratory study for analysis of clinical features and plasma catecholamines in blepharospasm
title_full_unstemmed A pilot exploratory study for analysis of clinical features and plasma catecholamines in blepharospasm
title_short A pilot exploratory study for analysis of clinical features and plasma catecholamines in blepharospasm
title_sort pilot exploratory study for analysis of clinical features and plasma catecholamines in blepharospasm
topic Blepharospasm
Pathogenesis
Anxiety
Catecholamine
3-methoxytyramine
url https://doi.org/10.1038/s41598-025-86922-y
work_keys_str_mv AT lixiazhu apilotexploratorystudyforanalysisofclinicalfeaturesandplasmacatecholaminesinblepharospasm
AT hongmeimeng apilotexploratorystudyforanalysisofclinicalfeaturesandplasmacatecholaminesinblepharospasm
AT wuqiongzhang apilotexploratorystudyforanalysisofclinicalfeaturesandplasmacatecholaminesinblepharospasm
AT lijuanwang apilotexploratorystudyforanalysisofclinicalfeaturesandplasmacatecholaminesinblepharospasm
AT weixuanzhao apilotexploratorystudyforanalysisofclinicalfeaturesandplasmacatecholaminesinblepharospasm
AT jiaaili apilotexploratorystudyforanalysisofclinicalfeaturesandplasmacatecholaminesinblepharospasm
AT nilupaershafeng apilotexploratorystudyforanalysisofclinicalfeaturesandplasmacatecholaminesinblepharospasm
AT huaiyusun apilotexploratorystudyforanalysisofclinicalfeaturesandplasmacatecholaminesinblepharospasm
AT tingjiang apilotexploratorystudyforanalysisofclinicalfeaturesandplasmacatecholaminesinblepharospasm
AT huiqingliu apilotexploratorystudyforanalysisofclinicalfeaturesandplasmacatecholaminesinblepharospasm
AT yuguo apilotexploratorystudyforanalysisofclinicalfeaturesandplasmacatecholaminesinblepharospasm
AT shuaihou apilotexploratorystudyforanalysisofclinicalfeaturesandplasmacatecholaminesinblepharospasm
AT lixiazhu pilotexploratorystudyforanalysisofclinicalfeaturesandplasmacatecholaminesinblepharospasm
AT hongmeimeng pilotexploratorystudyforanalysisofclinicalfeaturesandplasmacatecholaminesinblepharospasm
AT wuqiongzhang pilotexploratorystudyforanalysisofclinicalfeaturesandplasmacatecholaminesinblepharospasm
AT lijuanwang pilotexploratorystudyforanalysisofclinicalfeaturesandplasmacatecholaminesinblepharospasm
AT weixuanzhao pilotexploratorystudyforanalysisofclinicalfeaturesandplasmacatecholaminesinblepharospasm
AT jiaaili pilotexploratorystudyforanalysisofclinicalfeaturesandplasmacatecholaminesinblepharospasm
AT nilupaershafeng pilotexploratorystudyforanalysisofclinicalfeaturesandplasmacatecholaminesinblepharospasm
AT huaiyusun pilotexploratorystudyforanalysisofclinicalfeaturesandplasmacatecholaminesinblepharospasm
AT tingjiang pilotexploratorystudyforanalysisofclinicalfeaturesandplasmacatecholaminesinblepharospasm
AT huiqingliu pilotexploratorystudyforanalysisofclinicalfeaturesandplasmacatecholaminesinblepharospasm
AT yuguo pilotexploratorystudyforanalysisofclinicalfeaturesandplasmacatecholaminesinblepharospasm
AT shuaihou pilotexploratorystudyforanalysisofclinicalfeaturesandplasmacatecholaminesinblepharospasm